Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Assets Average (2020 - 2025)

Historic Assets Average for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $478.9 million.

  • GeneDx Holdings' Assets Average rose 2002.97% to $478.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $478.9 million, marking a year-over-year increase of 2002.97%. This contributed to the annual value of $419.1 million for FY2024, which is 786.66% down from last year.
  • According to the latest figures from Q3 2025, GeneDx Holdings' Assets Average is $478.9 million, which was up 2002.97% from $455.1 million recorded in Q2 2025.
  • Over the past 5 years, GeneDx Holdings' Assets Average peaked at $881.1 million during Q3 2022, and registered a low of $197.4 million during Q2 2021.
  • Its 5-year average for Assets Average is $477.7 million, with a median of $446.8 million in 2023.
  • As far as peak fluctuations go, GeneDx Holdings' Assets Average surged by 26748.73% in 2022, and later plummeted by 4928.8% in 2023.
  • Quarter analysis of 5 years shows GeneDx Holdings' Assets Average stood at $578.7 million in 2021, then rose by 14.04% to $660.0 million in 2022, then crashed by 36.66% to $418.0 million in 2023, then fell by 0.94% to $414.1 million in 2024, then increased by 15.64% to $478.9 million in 2025.
  • Its last three reported values are $478.9 million in Q3 2025, $455.1 million for Q2 2025, and $432.9 million during Q1 2025.